Gastroenterology
The complexity of gastrointestinal disorders demands a clinical research partner with deep therapeutic insight and operational agility. At Confidence Pharmaceutical Research, we bring both—supporting innovative trials that address inflammation, motility, and functional GI conditions.
Our work spans a wide range of indications, including inflammatory bowel disease, Eosinophilic Esophagitis (EoE), GERD, and postoperative complications. Whether supporting early-phase trials or managing large-scale, global studies, we’re committed to helping sponsors bring better digestive health treatments to market—faster and smarter.
Focus Areas
- Ulcerative Colitis
- Mucosal healing, disease activity indices, and long-term remission outcomes
- Gastroesophageal Reflux Disease (GERD)
- Symptom relief, esophageal pH monitoring, and device trials
- Fecal Incontinence
- Neuromodulation, behavioral therapies, and quality of life metrics
- Crohn’s Disease
- Biologic therapies, fistula management, and patient-reported outcomes
- Postoperative Ileus
- Accelerated GI recovery and motility improvement following surgery
- EoE (Eosinophilic Esophagitis)
- Biologic therapies, histologic remission, and dysphagia improvement